8Panos Kanavos. Providing Access to Modern Treatments and Influencing Policy in Orphan Diseases.. the International Experience and Evidence from the UK. LSE Health and Social Care [R]. 2005.
9Michael F. Drummond, David A. Wilson, Panos Kanavos. Assessing the economic challenges posed by orphan drugs[J]. InternationalJournal of Technology Assessment in Health Care, 2007,23(1):36-42.
10Marlene E Haffner. Adopting Orphan Drugs-Two Dozen Years of Treating Rare Diseases[J]. The New England Journal of Medicine. The New England Journal of Medicine. 2006, 354 (5) : 445-447.
